Quality-adjusted life-years accrued with cabozantinib in patients with advanced hepatocellular carcinoma in the CELESTIAL trial Meeting Abstract


Authors: Strasser, S.; Abou-Alfa, G.; Mollon, P.; Meyer, T.; Cheng, A.; El-Khoueiry, A.; Kelley, R.; Baron, A.; Benzaghou, F.; Valcheva, V.; Hazra, S.; Mangeshkar, M.; Freemantle, N.
Abstract Title: Quality-adjusted life-years accrued with cabozantinib in patients with advanced hepatocellular carcinoma in the CELESTIAL trial
Meeting Title: Australian Gastroenterology Week (AGW)
Journal Title: Journal of Gastroenterology and Hepatology
Volume: 34
Issue: Suppl. 2
Meeting Dates: 2019 Sept 8-10
Meeting Location: Adelaide, Australia
ISSN: 0815-9319
Publisher: Wiley Blackwell  
Date Published: 2019-09-01
Start Page: 43
Language: English
ACCESSION: WOS:000483843100067
PROVIDER: wos
DOI: 10.1111/jgh.14797
PUBMED: 31484220
Notes: Meeting Abstract: 444 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ghassan Abou-Alfa
    568 Abou-Alfa